Literature DB >> 35700038

Genome-Wide Association Study of Pregnancy in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.

Seth J Rotz1, Sarah Worley2, Bo Hu2, Peter Bazeley2, Jessica L Baedke3, Melissa M Hudson3,4, Dennis J Kuo5, Kevin C Oeffinger6, Leslie L Robison3, Debashis Sahoo7, Fan Wang3, Yutaka Yasui3, Gregory T Armstrong3, Smita Bhatia8.   

Abstract

BACKGROUND: Gonadotoxic treatment-related infertility has a significant impact on quality of life in childhood cancer survivors. Genome-wide association analyses to delineate the risk of infertility in childhood cancer survivors have not been previously reported.
METHODS: Leveraging genotype data from a large survivor cohort, the Childhood Cancer Survivor Study (CCSS), we investigated the role of SNPs on future pregnancy or siring a pregnancy in survivors without pelvic, testicular, or brain radiation who had ever been married. We calculated sex-stratified hazard ratios, using Cox proportional hazards modeling, adjusting for birth cohort (before 1965 vs. 1965 or later) and doses of relevant chemotherapies; replication was attempted in the independent St. Jude Lifetime Cohort study (SJLIFE).
RESULTS: In the CCSS cohort, nine SNPs were found to be suggestive (P < 10-7) or statistically significantly (P < 5 × 10-8) associated with pregnancy, however, none of the SNPs were replicated in SJLIFE. Cohorts differed based on the overall pregnancy rate, frequency of sterilizing procedures, and birth cohort.
CONCLUSIONS: We were not able to replicate our findings of SNPs associated with pregnancy in childhood cancer survivors. IMPACT: Future attempts at replication should be considered in cohorts treated in a comparable era. In addition, understanding the role of genetics in fertility in childhood cancer survivors may be better approached using more advanced sequencing techniques. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2022        PMID: 35700038      PMCID: PMC9444932          DOI: 10.1158/1055-9965.EPI-22-0314

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  8 in total

1.  Whole-Genome Sequencing of Childhood Cancer Survivors Treated with Cranial Radiation Therapy Identifies 5p15.33 Locus for Stroke: A Report from the St. Jude Lifetime Cohort Study.

Authors:  Kevin R Krull; Yutaka Yasui; Yadav Sapkota; Yin Ting Cheung; Wonjong Moon; Kyla Shelton; Carmen L Wilson; Zhaoming Wang; Daniel A Mulrooney; Jinghui Zhang; Gregory T Armstrong; Melissa M Hudson; Leslie L Robison
Journal:  Clin Cancer Res       Date:  2019-08-28       Impact factor: 12.531

2.  Power and sample size calculations for SNP association studies with censored time-to-event outcomes.

Authors:  Kouros Owzar; Zhiguo Li; Nancy Cox; Sin-Ho Jung
Journal:  Genet Epidemiol       Date:  2012-06-08       Impact factor: 2.135

Review 3.  Development of a Pediatric Fertility Preservation Program: A Report From the Pediatric Initiative Network of the Oncofertility Consortium.

Authors:  Molly B Moravek; Leslie C Appiah; Antoinette Anazodo; Karen C Burns; Veronica Gomez-Lobo; Holly R Hoefgen; Olivia Jaworek Frias; Monica M Laronda; Jennifer Levine; Lillian R Meacham; Mary Ellen Pavone; Gwendolyn P Quinn; Erin E Rowell; Andrew C Strine; Teresa K Woodruff; Leena Nahata
Journal:  J Adolesc Health       Date:  2019-01-14       Impact factor: 5.012

Review 4.  Genetic susceptibility to male infertility: news from genome-wide association studies.

Authors:  K I Aston
Journal:  Andrology       Date:  2014-02-19       Impact factor: 3.842

5.  Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort.

Authors:  Eric J Chow; Kayla L Stratton; Wendy M Leisenring; Kevin C Oeffinger; Charles A Sklar; Sarah S Donaldson; Jill P Ginsberg; Lisa B Kenney; Jennifer M Levine; Leslie L Robison; Margarett Shnorhavorian; Marilyn Stovall; Gregory T Armstrong; Daniel M Green
Journal:  Lancet Oncol       Date:  2016-03-22       Impact factor: 41.316

6.  Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.

Authors:  Lindsay M Morton; Joshua N Sampson; Gregory T Armstrong; Ting-Huei Chen; Melissa M Hudson; Eric Karlins; Casey L Dagnall; Shengchao Alfred Li; Carmen L Wilson; Deo Kumar Srivastava; Wei Liu; Guolian Kang; Kevin C Oeffinger; Tara O Henderson; Chaya S Moskowitz; Todd M Gibson; Diana M Merino; Jeannette R Wong; Sue Hammond; Joseph P Neglia; Lucie M Turcotte; Jeremy Miller; Laura Bowen; William A Wheeler; Wendy M Leisenring; John A Whitton; Laurie Burdette; Charles Chung; Belynda D Hicks; Kristine Jones; Mitchell J Machiela; Aurelie Vogt; Zhaoming Wang; Meredith Yeager; Geoffrey Neale; Matthew Lear; Louise C Strong; Yutaka Yasui; Marilyn Stovall; Rita E Weathers; Susan A Smith; Rebecca Howell; Stella M Davies; Gretchen A Radloff; Kenan Onel; Amy Berrington de González; Peter D Inskip; Preetha Rajaraman; Joseph F Fraumeni; Smita Bhatia; Stephen J Chanock; Margaret A Tucker; Leslie L Robison
Journal:  J Natl Cancer Inst       Date:  2017-11-01       Impact factor: 13.506

7.  Clinical ascertainment of health outcomes among adults treated for childhood cancer.

Authors:  Melissa M Hudson; Kirsten K Ness; James G Gurney; Daniel A Mulrooney; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Gregory T Armstrong; Kerri A Nottage; Kendra E Jones; Charles A Sklar; Deo Kumar Srivastava; Leslie L Robison
Journal:  JAMA       Date:  2013-06-12       Impact factor: 56.272

8.  The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.

Authors:  Daniel M Green; Vikki G Nolan; Pamela J Goodman; John A Whitton; DeoKumar Srivastava; Wendy M Leisenring; Joseph P Neglia; Charles A Sklar; Sue C Kaste; Melissa M Hudson; Lisa R Diller; Marilyn Stovall; Sarah S Donaldson; Leslie L Robison
Journal:  Pediatr Blood Cancer       Date:  2013-08-12       Impact factor: 3.167

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.